Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00834600 · ClinicalTrials.gov registry record · NA

Renin Profiling in Selection of Initial Antihypertensive Drug

A NA study of Hypertension, sponsored by The Louis & Rachel Rudin Foundation.

Completed
Registry status
NA
Development phase
185
Enrollment target
5
Study locations

NCT00834600: Completed NA study of Hypertension, sponsored by The Louis & Rachel Rudin Foundation.

NCT00834600 is a NA study of Hypertension that has completed, run by The Louis & Rachel Rudin Foundation. The registered enrollment target is 185 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (95% lower). The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00834600, a NA study of Hypertension, has completed, sponsored by The Louis & Rachel Rudin Foundation.

COMPLETED
Registry status
NA
Development phase
185 participants
Enrollment target
5
Study locations

Study Summary

The purpose of this research study is to determine whether a simple blood test measuring a hormone called renin can better determine which first drug would be most effective in controlling blood pressure, in comparison with the more traditional approach recommended by JNC7 (Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure).

Conditions Studied

Interventions

  • DRUG olmesartan, hydrochlorothiazide, amlodipine
  • DRUG hydrochlorothiazide (HCTZ) or olmesartan

Study Locations (5)

New York

  • Lincoln Medical and Mental Health Center - The Bronx
  • Albert Einstein College of Medicine - GCRC - The Bronx
  • Jacobi Medical Center - The Bronx
  • Bronx Nephrology Hypertension, PC - The Bronx
  • Ralph Yung, MD - The Bronx

Trial Details

FieldValue
Enrollment Target 185 participants
Start Date 2005-12
Est. Completion 2011-10
Phase NA

What the finished NCT00834600 record still lists

NCT00834600 is an interventional study that assigns participants to a tested intervention. The registered 185 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which olmesartan, hydrochlorothiazide, amlodipine is the first listed.

NCT00834600 lists 5 locations in 1 state (New York).

Frequently Asked Questions

What is clinical trial NCT00834600 about?

NCT00834600 is a clinical study titled "Renin Profiling in Selection of Initial Antihypertensive Drug". The purpose of this research study is to determine whether a simple blood test measuring a hormone called renin can better determine which first drug would be most effective in controlling blood pressure, in comparison with the more traditional approach recommended by JNC7 (Joint National Committee ...

What is the current status of trial NCT00834600?

This trial is currently completed. It is a NA study. The enrollment target is 185 participants. The study started on 2005-12. Estimated completion is 2011-10.

What conditions does trial NCT00834600 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT00834600?

The interventions under investigation include: olmesartan, hydrochlorothiazide, amlodipine (DRUG), hydrochlorothiazide (HCTZ) or olmesartan (DRUG).

Who is sponsoring clinical trial NCT00834600?

This trial is sponsored by The Louis & Rachel Rudin Foundation, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00834600 being conducted?

This trial has 5 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00834600's enrollment target sits among peer trials

185 228th of 470 higher than 243 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04041154 · 185 participants · NA

    Behavioral and Neural Representations of Subjective Effort Cost

  • NCT04484272 · 185 participants · NA

    A Stress and Pain Self-management m-Health App for Adult Outpatients With Sickle Cell Disease

  • NCT05020860 · 185 participants · Phase 2

    Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer

  • NCT05793541 · 185 participants · NA

    Just-in-time Interventions for Reducing Short-term Suicide Risk

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00834600, the US trial registry maintained by the National Library of Medicine. NCT00834600 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.